We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Classification and Longitudinal Follow-up of Common Melanocytic Nevi With in Vivo Reflectance Confocal Microscopy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by Sheba Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01194947
First Posted: September 3, 2010
Last Update Posted: September 3, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
  Purpose
Our working hypothesis is that reflectance confocal microscopy (RCM) can identify distinct subsets of melanocytic nevi that retain their distinctive pattern over time.

Condition Intervention
Common Melanocytic Nevi Device: RCM imaging

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Primary Outcome Measures:
  • Inter-rater agreement on assignment of nevi to RCM patterns (baseline and follow-up images). [ Time Frame: 3 YEARS ]

Secondary Outcome Measures:
  • Description of rates of retention and change in RCM pattern of nevi during follow-up [ Time Frame: 3 YEARS ]

Estimated Enrollment: 90
Study Start Date: September 2010
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Study participants
patients 18 or older presenting to the Sheba Medical Center pigmented lesion clinic for skin cancer surveillance. Patients routinely undergo total skin examination that includes clinical and dermoscopic evaluation of skin lesions. Patients also routinely undergo annual total body digital photography that allows identification of new or changing lesions.
Device: RCM imaging
RCM imaging will be performed using a commercially-available RCM (Vivascope 1500, Lucid Inc, Rochester, NY, USA) with 830-nm diode laser with emitting power less than 35 milliwatts

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients visiting the pigmented lesion clinic for skin cancer surveillance
Criteria

Inclusion Criteria:

  • Patients visiting the Sheba Medical Center pigmented lesion clinic for skin examination
  • Patients having at least three banal-appearing nevi, one on the upper back, one on the lower back and one on the lower extremity (excluding foot), which are amenable for RCM examination.

Exclusion Criteria:

  • Patients who are unwilling or medically unable to lie down for 30 minutes.
  • Pregnant women
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01194947


Contacts
Contact: ALON SCOPE, MD 972-3-5302443 scopea1@gmail.com

Locations
Israel
Sheba Medical Center Not yet recruiting
Rmat-gan, Israel, 52621
Contact: ALON SCOPE, MD    972-3-5302443      
Principal Investigator: ALON SCOPE, MD         
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: ALON SCOPE, MD Sheba Medical Center
  More Information

Responsible Party: DR. ALONE SCOPE, SHEBA MEDICAL CENTER
ClinicalTrials.gov Identifier: NCT01194947     History of Changes
Other Study ID Numbers: SHEBA-10-8015-AS-CTIL
First Submitted: September 2, 2010
First Posted: September 3, 2010
Last Update Posted: September 3, 2010
Last Verified: September 2010

Keywords provided by Sheba Medical Center:
banal-appearing nevi
NEVUS

Additional relevant MeSH terms:
Nevus
Nevus, Pigmented
Nevus, Epithelioid and Spindle Cell
Nevi and Melanomas
Neoplasms by Histologic Type
Neoplasms
Nevus, Spindle Cell